Emergent BioSolutions, Inc. (NYSE:EBS)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

Recs

0
Player Avatar Ulenspiegel101 (< 20) Submitted: 6/2/2009 3:07:11 PM : Outperform Start Price: $11.89 EBS Score: -25.03

proven innovator

Featured Broker Partners


Advertisement